Press Releases

Date	Title and Summary	Additional Formats
January 8, 2025	Vericel to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025	View HTML PDF Version
November 7, 2024	Vericel Reports Third Quarter 2024 Financial Results	View HTML PDF Version
October 24, 2024	Vericel to Report Third-Quarter 2024 Financial Results on November 7, 2024	View HTML PDF Version
August 29, 2024	Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024	View HTML PDF Version
August 26, 2024	Vericel Announces FDA Approval and Commercial Availability of MACI Arthro	View HTML PDF Version
August 15, 2024	Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns	View HTML PDF Version
August 7, 2024	Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024	View HTML PDF Version
August 1, 2024	Vericel Reports Second Quarter 2024 Financial Results	View HTML PDF Version
July 22, 2024	Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer	View HTML PDF Version
July 18, 2024	Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024	View HTML PDF Version

Investor Relations